Lilly Asia Ventures achieved an exit in a Hong Kong offering in which the oncology therapy developer floated at the top of its range.

The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Saudi Aramco and Schlumberger.

The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Utec.

Bar-Ilan University’s textile developer Sonovia has completed an $18.5m initial public offering on the Tel Aviv Stock Exchange.

Sony, Opt, Gree and NEC scored exits as the online investment platform developer went public on the Tokyo Stock Exchange.

UTokyo Innovation Platform has scored an exit as the online investment platform developer went public on the Tokyo Stock Exchange.

Rakuten, Progressive and Alphabet-backed online lending platform Upstart has closed its initial public offering, its share price having more than doubled since it floated.

The Saudi Aramco and Schlumberger-backed chemical analysis device makers shares have nearly tripled in price since it went public on Friday.

The UBC-linked antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.

The Eli Lilly-backed antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.